Regeneron Ventures

Venture capital firm

Portfolio

1 total
Infinimmune

Recent Investment Activity

1
DateCompanyEventAmountValuationInvestorsSource
Aug 11, 2026InfinimmuneSeries A$75M—
Regeneron VenturesCivilization VenturesPear VCMerck Global Health Innovation FundEverbright Biofund
outlined = lead
Pulse story

Co-Investors

2
Civilization Ventures · 1 sharedPear VC · 1 shared

Latest Pulse

Pulse coverage →
  1. Infinimmune Raises $75M for Human-Derived Antibody DrugsInfinimmune raised a $75 million Series A co-led by Regeneron Ventures and Playground Global to advance two atopic dermatitis antibody candidates built from its human-derived Anthrobody platform.→
Sources & methodologyshow
Where these figures come from

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data · Suggest a correction